• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Spring into Rejuvenated Goals in Your Practice

Publication
Article
Dermatology TimesDermatology Times, April 2023 (Vol. 44. No. 04)
Volume 44
Issue 04

DOC RABE Media/AdobeStock
DOC RABE Media/AdobeStock

Now that we’re 4 months into 2023, many New Year’s resolutions have ended up in the rearview mirror. The great thing about goal setting is that there is not a right or wrong time to recharge your batteries and determine what you would like to accomplish in both your personal and professional life. The Dermatology Times® team has you covered, whether you are interested in integrating new technology into your treatment options, familiarizing yourself with rare skin conditions, or locking inyour practice’s legal and financial security.

In this month’s issue, learn about the latest technology available to treat port-wine stains, as well as the striking before and after results; take a look at the connection between lipid-lowering drugs and psoriasis management; and learn about the latest in rosacea treatment as we recognize Rosacea Awareness Month. On the medical practice side of things, you will discover how to master tax-favored assets with David B. Mandell, JD, MBA, and Carole C. Foos, CPA. They answer questions on finding assets that will grow taxfree over time to help you build on your financial future. April’s Legal Eagle column with David J. Goldberg, MD, JD, outlines who is liable for what in an electronic health record system glitch. He also shares insight on how you can best protect your practice and sensitive data.

We look forward to continually serving you with news to enhance dermatologic care, your practice, and patient outcomes. Be sure to stay connected with the Dermatology Times team between print issues by following us on social media, subscribing to e-newsletters, and emailing article ideas and insights to DTEditor@mmhgroup.com.

Mike Hennessy Jr

President and CEO, MJH Life Sciences®

Related Videos
© 2024 MJH Life Sciences

All rights reserved.